Interferon signaling restrains renal cell carcinoma heterogeneity

Peter Holicek, Jitka Fucikova, Lorenzo Galluzzi

Research output: Contribution to journalArticlepeer-review

Abstract

Type I interferon (IFN) is central to cancer surveillance as it mediates both direct and immune-mediated oncosuppressive effects. A recent study by Perelli et al. suggests that the ability of renal cancer cells to tolerate complex karyotypic alterations elicited by chromosomal instability (CIN), and ultimately acquire full metastatic potential, is also negatively regulated by IFN signaling.

Original languageEnglish
Pages (from-to)871-873
Number of pages3
JournalTrends in Cancer
Volume9
Issue number11
DOIs
StatePublished - Nov 2023
Externally publishedYes

Keywords

  • cancer stem cells
  • cancer/immunity coevolution
  • CGAS
  • CNV
  • immunoevasion
  • Signal Transduction
  • Kidney Neoplasms/genetics
  • Humans
  • Nucleotidyltransferases/metabolism
  • Interferon Type I/metabolism
  • Carcinoma, Renal Cell/genetics

Fingerprint

Dive into the research topics of 'Interferon signaling restrains renal cell carcinoma heterogeneity'. Together they form a unique fingerprint.

Cite this